Aya-ay, Godafreda .
HRN: 18-20-46 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/19/2025
CEFTRIAXONE 1G (VIAL)
09/19/2025
09/26/2025
IV
2g
OD
Typhoid Fever
Checking Initial Appropriateness
09/22/2025
MUPIROCIN 2%, 15G (TUBE)
09/22/2025
09/29/2025
TOPICAL
2%
BID
Infected Wound
Checking Initial Appropriateness